Filed: 11/13/2024ACC: 0000895345-24-000559
📋 What this filing means
ALERCE INVESTMENT MANAGEMENT, L.P. filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $62.32M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$62.32M
Total AUM (reported)
13.88M
Total Shares
Allocation by class
COM$51.43M82.5%
SPONSORED ADS$5.92M9.5%
COM CL A NEW$4.97M8.0%
Portfolio Concentration
Top 3$57.35M92.0%
4–10$4.97M8.0%
Top 3 weight
92.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 13.88M
Sole
Full voting authority
13.88M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
ANNEXON INC
SOLEShares7.41M
TypeSH
Market value$43.84M
70.35%
Sole
7.41M
Shared
0.00
None
0.00
AKEBIA THERAPEUTICS INC
SOLEShares5.75M
TypeSH
Market value$7.59M
12.17%
Sole
5.75M
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares205.88K
TypeSH
Market value$5.92M
9.50%
Sole
205.88K
Shared
0.00
None
0.00
AMERICAN WELL CORP
SOLEShares523.78K
TypeSH
Market value$4.97M
7.97%
Sole
523.78K
Shared
0.00
None
0.00
AADI BIOSCIENCE INC
SOLEShares659.00
TypeSH
Market value$1.4K
<0.01%
Sole
659.00
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ANNEXON INCSOLE | COM | 7.41M | SH | $43.84M 70.35% | 7.41M | 0.00 | 0.00 |
AKEBIA THERAPEUTICS INCSOLE | COM | 5.75M | SH | $7.59M 12.17% | 5.75M | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 205.88K | SH | $5.92M 9.50% | 205.88K | 0.00 | 0.00 |
AMERICAN WELL CORPSOLE | COM CL A NEW | 523.78K | SH | $4.97M 7.97% | 523.78K | 0.00 | 0.00 |
AADI BIOSCIENCE INCSOLE | COM | 659.00 | SH | $1.4K <0.01% | 659.00 | 0.00 | 0.00 |